Loading...
XJPX
2216
Market cap100mUSD
Jul 10, Last price  
1,160.00JPY
1D
-1.53%
1Q
-3.89%
Jan 2017
-60.48%
Name

Kanro Inc

Chart & Performance

D1W1MN
XJPX:2216 chart
P/E
4.76
P/S
0.46
EPS
243.62
Div Yield, %
2.63%
Shrs. gr., 5y
-0.08%
Rev. gr., 5y
8.32%
Revenues
34.77b
+9.42%
21,745,000,00020,648,000,00021,105,000,00020,710,859,00019,900,972,00020,332,183,00020,351,099,00018,310,018,00018,805,330,00019,683,098,00019,716,781,00021,301,794,00022,949,928,00024,039,072,00023,321,485,00021,589,811,00025,118,401,00029,015,855,00031,778,392,00034,771,829,000
Net income
3.38b
+3.64%
584,000,000799,000,000709,000,000763,719,000615,654,000402,219,000301,671,00046,081,000-495,570,00086,900,000500,590,000593,974,0001,011,665,000651,999,000610,513,000879,017,0001,346,355,0002,462,532,0003,260,024,0003,378,807,000
CFO
5.05b
+14.88%
768,000,0001,776,000,0001,621,000,0001,691,932,0001,455,333,0001,511,991,0001,635,666,0001,088,055,000600,337,0001,469,946,0001,970,044,0001,512,885,000949,483,0002,013,863,0001,442,503,0002,620,309,0002,373,795,0003,935,829,0004,398,439,0005,053,097,000
Dividend
Dec 29, 202618 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Kanro Inc., a Japanese firm headquartered in Tokyo and established in 1950, specializes in the manufacturing and sale of a diverse range of confectionery and food products. Its extensive portfolio includes items such as throat lozenges, various types of candies, chewy gummies, soft marshmallows, and innovative, ingredient-driven snacks. These goods are marketed under numerous prominent brand names, among them Kanro Candy, Puré Gummy, Candemina Gumi, Gold Milk, Play! Gummy, Marosh, and specialized lines like healthy throat lozenges and herbal good products, in addition to many other proprietary labels.
URL
https://www.kanro.co.jp/
IPO date
Sep 28, 1962
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT